Australia markets open in 4 hours 47 minutes

GRI Bio, Inc. (GRI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2945+0.0065 (+2.26%)
As of 03:12PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.09M
Enterprise value -2.85M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.39
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-99.32%
S&P500 52-week change 324.69%
52-week high 347.9500
52-week low 30.2660
50-day moving average 30.4600
200-day moving average 34.1667

Share statistics

Avg vol (3-month) 3324.63k
Avg vol (10-day) 3715.83k
Shares outstanding 53.77M
Implied shares outstanding 63.77M
Float 83.62M
% held by insiders 13.54%
% held by institutions 16.21%
Shares short (15 May 2024) 424.33k
Short ratio (15 May 2024) 40.2
Short % of float (15 May 2024) 40.66%
Short % of shares outstanding (15 May 2024) 40.64%
Shares short (prior month 15 Apr 2024) 418.26k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:7
Last split date 330 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-279.42%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -12.04M
Net income avi to common (ttm)-12.77M
Diluted EPS (ttm)-4.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.09M
Total cash per share (mrq)1.08
Total debt (mrq)152k
Total debt/equity (mrq)5.43%
Current ratio (mrq)2.64
Book value per share (mrq)0.88

Cash flow statement

Operating cash flow (ttm)-10.61M
Levered free cash flow (ttm)-7.46M